Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia
Learn more about:
Related Clinical Trial
Randomized Controlled Crossover Trial of Postpyloric Feedings to Improve Pulmonary Outcomes in High-risk Preterm Infants
Effect of Caffeine Versus Probiotic on Preterm Neonates With Bronchopulmonary Dysplasia
Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
Corticosteroid Use in Premature Babies and Lung Ultrasonografi Use in the Progression to Bronchopulmonary Dysplasia
PAL to Improve Oral Feeding for Infants With Chronic Lung Disease
Exposure to Plasticisers in the Neonatal Intensive Care Unit
Implementation of a Consensus-Based Discharge Protocol for Preterm Infants With Lung Disease
Prediction for Bronchopulmonary Dysplasia
Baby Lung: an Observational Study
The Role of Transthoracic Echocardiography in Diagnosis of Pulmonary Hypertension of Infants With Bronchopulmonary Dysplasia
Body Weight Growth After Birth and Bronchopulmonary Dysplasia
Outcome of Extremely Preterm Infants Who Received Systemic Postnatal Corticosteroid for Bronchopulmonary Dysplasia
Comparison of the Acute Effects of Chest Physiotherapy Methods Applied in Different Positions in Preterm Newborns
Maintaining Optimal HVNI Delivery Using Automatic Titration of Oxygen in Preterm Infants
Impact of Steroid, Diuretic, and Fluid Use on BPD Outcomes
Ultrasound Assessment of Diaphragmatic Function in Infants With BPD
Ventilation-perfusion (V/Q) Ratio and Alveolar Surface Area in Preterm Infants
Nasal High-frequency Oscillatory Ventilation (NHFOV) for Ventilated Newborn Infants With BPD
Prone Versus Supine Positioning and the Impact on Bronchopulmonary Dysplasia in Very Low Birth Weight Infants.
Intratracheal Budesonide With Surfactant to Prevent Bronchopulmmonary Dysplasia.
NAVA vs. CMV Crossover in Severe BPD
CPAP Or Nasal Cannula Oxygen for Preterm Infants: A Randomized Controlled Trial
Lung Ultrasound for Early Identification of Preterm Infants With Bronchopulmonary Dysplasia
Phase 1b/2 Study on AT-100 Intervention (rhSP-D) in Preterm Neonates at High Risk for Development of Bronchopulmonary Dysplasia (BPD)
Inhaled Treatment for Bronchopulmonary Dysplasia
Phase 1 Trial of Inhaled Tobramycin in BPD
The Budesonide in Babies (BiB) Trial
Follow-up Results of Newborns With Tracheostomy
Safety of Sildenafil in Premature Infants With Severe Bronchopulmonary Dysplasia
Prolonged Outcomes After Nitric Oxide (PrONOx)
A Study of Tobacco Smoke and Children With Respiratory Illnesses
Delivery Room CPAP in Extremely Low Birth Weight Infants
Dexamethasone Therapy in VLBW Infants at Risk of CLD
Palivizumab for Prevention of Severe Respiratory Syncytial Virus Infection in Russian Children
Estimating Length of Endotracheal Tube Insertion Using Gestational Age or Nasal-Tragus Length in Newborn Infants
MRI as a Means to Measure Lung Function: Non-Invasive Imaging in Neonates and Children
Seattle-PAP Bubble Nasal CPAP and Work of Breathing
High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Blood Oxygenation and Stability of Oxygenation
Comparing Two Different Modes of Ventilation in Pretem Neonates Bilevel VG and PRVC
High Frequency Oscillatory Ventilation Combined With Intermittent Sigh Breaths: Effects on Lung Volume Monitored by Electric Tomography Impedance.
Functional and Lymphocytic Markers of Respiratory Morbidity in Hyperoxic Preemies
High Frequency Ventilation in Premature Infants (HIFI)
Early Caffeine in Preterm Neonates
Vitamin A Supplementation for Extremely-Low-Birth-Weight Infants
Non-invasive Respiratory Support in Preterm Infants
Pilot Trial of Surfactant Booster Prophylaxis For Ventilated Preterm Neonates
Randomized Trial of Nasal Continuous Positive Airway Pressure or Synchronized Nasal Ventilation in Premature Infants.
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
Work of Breathing During Non-invasive Ventilation in Premature Neonates
Inhaled Nitric Oxide for Preventing Chronic Lung Disease in Premature Infants
Intratracheal Budesonide/Surfactant Prevents BPD
Bronchopulmonary Disease (BPD) Patient Registry
Premature Birth and Its Sequelae in Women
Inhaled NO in Prevention of Chronic Lung Disease
The Effects of Position on the Oxygenation Instability of Premature Infants as Documented by SpO2 Histograms
Trial of Late Surfactant to Prevent BPD: A Pilot Study in Ventilated Preterm Neonates Receiving Inhaled Nitric Oxide
Exosurf Neonatal and Survanta for Treatment of Respiratory Distress Syndrome
Continuous Positive Airway Pressure Via Binasal Prong vs Nasal Mask: a Randomised Controlled Trial
Randomized Trial of Hydrocortisone in Very Preterm High-Risk Infants
Early NCPAP Before Surfactant Treatment in Very Preterm Infants With RDS
Continuous Versus Intermittent Bolus Feeding in Very Preterm Infants – Effect on Respiratory Morbidity
Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
Growth of Airways and Lung Tissues in Premature and Healthy Infants
Duration of Continuous Positive Airway Pressure and Pulmonary Function Testing in Preterm Infants
Assessment of Lung Structure and Function of Infants Born Prematurely
Post-hospitalization Nursing Effectiveness (PHONE) Study
Assessment of the Pulmonary Diffusion Capacity in Healthy Infants and Infants With Chronic Lung Disease
NCPAP + Heliox as a Treatment for Infant Respiratory Distress Syndrome (RDS)
Neurotrophin Expression in Infants as a Predictor of Respiratory and Neurodevelopmental Outcomes
Inhaled Beclomethasone to Prevent Chronic Lung Disease
Work of Breathing in Premature Infants at Discharge
Neolifes Heart – Pulmonary Hypertension in Preterm Children
Thrombocytopoiesis and Platelet Homeostasis in Infants With Bronchoplumonary Dysplasia
Efficacy of Recombinant Human Clara Cell 10 Protein (rhCC10) Administered to Premature Neonates With Respiratory Distress Syndrome
Hydrocortisone for BPD
Clinic Features and Outcome of BPD (SGBPD)
Management of Hyponatremia in Preterm Infants on Diuretics
Steroids and Surfactant in Extremely Low Gestation Age Infants Dose Escalation Trial
Respiratory Outcome at Adolescence of Very Low Birthweight Infants
Surfactant Administration During Spontaneous Breathing
Determining the Effect of Spironolactone on Electrolyte Supplementation in Preterm Infants With Chronic Lung Disease
Developmental Sequelae of Severe Chronic Lung Disorders
Long-term Safety and Efficacy Follow-up Study of PNEUMOSTEM® in Patients Who Completed PNEUMOSTEM® Phase-I Study
Indoor Air Quality and Respiratory Morbidity in School-Aged Children With BPD
Study of Nasal Ventilation In Preterm Infants To Decrease Time on The Respirator
Follow-up Study of Safety and Efficacy in Subjects Who Completed PNEUMOSTEM® Phase II (MP-CR-012) Clinical Trial
Follow-up Safety and Efficacy Evaluation on Subjects Who Completed PNEUMOSTEM® Phase-II Clinical Trial
Tidal Neonatal NO, Vitamins A and D, and Infant Lung Disease – The AD-ON Study
Nasal Mask and Prong Use in Non-invasive Ventilation for Newborns
Improving Prematurity-Related Respiratory Outcomes at Vanderbilt
Study of Inhaled Nitric Oxide (iNO) and Respiratory Outcomes in Late Preterm Infants
Azithromycin in the Prevention of Lung Injury in Premature Newborn
Randomized Control Trial: Synchronized Non-invasive Positive Pressure Ventilation Versus Non Synchronized Non Invasive Positive Pressure Ventilation in Extremely Low Birth Weight Infants
Neurally Adjusted Ventilatory Assist vs Proportional Assist Ventilation
MRI in BPD Subjects
A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD
Hypercapnia and Its Association With Long-term Respiratory Morbidities in Premature Infants With Chronic Lung Disease
Early Versus Late Caffeine for ELBW Newborns
Assessment of Lung Aeration at Birth
MRI of Lung Structure and Function in Preterm Children
BPD Saturation TARgeting
Use of Human Milk Cream to Decrease Length of Stay in Extremely Premature Infants
Effect of Synchronized vs. Continuous HFNC Using NAVA on WOB in Infants With BPD
Late Sequelae of Bronchopulmonary Dysplasia
Montelukast in Very Low Birthweight Infants
Antecedents of Bronchopulmonary Dysplasia
Pulmonary Outcomes of Bronchopulmonary Dysplasia in Young Adulthood
Aerosolized Albuterol Use in Severe BPD
Preterm Infant Inhaled Albuterol Dosing
129Xe MRI in Pediatric Population With BPD
Investigation of Polymorphisms in Bronchopulmonary Dysplasia In Turkish Population
Pulmonary MRI of Ex-preterm Children With and Without BPD To Understand Risk of Emphysematous Changes
Comparison of Classification Standards of BPD in Premature Infants
Inhaled Corticosteroids for Treatment of Bronchopulmonary Dysplasia
Safety of Sildenafil in Premature Infants
Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
Intratracheal Umbilical Cord-derived Mesenchymal Stem Cells for Severe Bronchopulmonary Dysplasia
Phase III Randomized, Double-Blind Study of Dexamethasone Vs Dexamethasone/Methylprednisolone Vs Placebo for Bronchopulmonary Dysplasia
Impact of an Exercise Program for Children Aged 4 to 6 Years With Bronchopulmonary Dysplasia
Trial II of Lung Protection With Azithromycin in the Preterm Infant
Enteral Zinc to Improve Growth in Infants at Risk for Bronchopulmonary Dysplasia
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
The Efficacy and Safety of Montelukast Sodium in the Prevention of Bronchopulmonary Dysplasia
L-citrulline and Pulmonary Hypertension Associated With Bronchopulmonary Dysplasia
The Role of Anti-Reflux Surgery for Gastroesophageal Reflux Disease in Premature Infants With Bronchopulmonary Dysplasia
Fluid Filled Lung Oxygenation Assistance Trial
Trial of Late Surfactant for Prevention of Bronchopulmonary Dysplasia
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Exogenous Surfactant in Very Preterm Neonates in Prevention of Bronchopulmonary Dysplasia
Follow-Up Study of Safety and Efficacy of Pneumostem® in Premature Infants With Bronchopulmonary Dysplasia
Risk Factors in Bronchopulmonary Dysplasia (Newborn Lung Project)
Pilot Study of Topical Steroid for Prevention of Chronic Lung Disease in Extremely Premature Infants.
Bronchopulmonary Dysplasia: From Neonatal Chronic Lung Disease to Early Onset Adult COPD
Gastrin-Releasing Peptide and Bronchopulmonary Dysplasia
Benchmarking Initiative to Reduce Bronchopulmonary Dysplasia
Human Mesenchymal Stem Cells For Infants At High Risk For Bronchopulmonary Dysplasia
SURFAXIN® Treatment for Prevention of Bronchopulmonary Dysplasia (BPD) in Very Low Birth Weight (VLBW) Infants.
Physiologic Definition of Bronchopulmonary Dysplasia
Safety and Efficacy of PNEUMOSTEM® in Premature Infants at High Risk for Bronchopulmonary Dysplasia (BPD) – a US Study
Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia
Safety of Furosemide in Premature Infants at Risk of Bronchopulmonary Dysplasia (BPD)
Mesenchymal Stem Cells for The Treatment of Bronchopulmonary Dysplasia in Infants
p16Ink4a in Bronchopulmonary Dysplasia in Children
Transpyloric Feeding in Severe Bronchopulmonary Dysplasia
Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia
Phase 1 Intravenous Citrulline for the Prevention of Bronchopulmonary Dysplasia in Preterm Infants
Epidemiological Study for Bronchopulmonary Dysplasia (BPD) in China
PREMILOC Trial to Prevent Bronchopulmonary Dysplasia in Very Preterm Neonates
Stem Cells for Bronchopulmonary Dysplasia
Hydrotherapy in Premature Infants With Bronchopulmonary Dysplasia
Safety and Efficacy Evaluation of PNEUMOSTEM® Treatment in Premature Infants With Bronchopulmonary Dysplasia
Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)
Efficacy and Safety of Inhaled Budesonide in Very Preterm Infants at Risk for Bronchopulmonary Dysplasia
Inhaled Nitric Oxide (INO) for the Prevention of Bronchopulmonary Dysplasia (BPD) in Preterm Infants
Prospective Study on Plasma Pro-endothelin-1 in Predicting Bronchopulmonary Dysplasia
Interest of Pulmonary Ultrasound to Predict Evolution Towards Bronchopulmonary Dysplasia in Premature Infants at Gestational Age Less Than or Equal to 34 Weeks of Gestation
Study to Justify Steroid Use in Preterm Neonates to Prevent Bronchopulmonary Dysplasia
Efficacy of Adding Budesonide to Poractant Alfa to Prevent Bronchopulmonary Dysplasia.
Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia
Human Mesenchymal Stem Cells For Moderate and Severe Bronchopulmonary Dysplasia
Genetic Susceptibility for Bronchopulmonary Dysplasia in Preterm Infants
Respiratory Management of Preterm Infants and Bronchopulmonary Dysplasia